The future of the weight loss market might not revolve around GLP-1 drugs.

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

As prices for Ozempic have risen in recent months, many people may be seeking cheaper alternatives for managing diabetes or weight loss. Dr. Brett Osborn and Dr. Sue Decotiis warn of potential risks.

A new CDC report reveals that over 15.5 million U.S. adults have ADHD, with 71.5 per cent facing difficulties obtaining ...

India’s powerful copycat pharmaceutical industry is set to roll out generic weight-loss drugs in the UK within weeks, with one leading producer forecasting a “huge price war t ...

In the ever-changing healthcare landscape, it is crucial to develop sustainable long-term strategies that look beyond ...

We love hearing from you. Lilah is on Instagram @ lilahrap, and email at [email protected]. And we’re grateful for reviews on Apple and Spotify! – Jo’s column about the silence around weight loss in ...

New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

This is an audio transcript of the Life and Art from FT Weekend podcast episode: ‘Fashion loves Ozempic. Should we talk about it?’ ...

Novo Nordisk CEO Lars Fruergaard Jorgensen has called attention to the complexities of the U.S. healthcare system while ...

New drugs from public and private companies are expected to saturate the obesity drug market. Novo Nordisk and Eli Lilly are currently dominating the weight loss drug market, but biopharmaceutical ...

I don’t normally pay much attention to the world of high fashion, but the controversy sparked by last month’s Paris fashion ...